Statutory Instrument 156/2023, the Misuse of Drugs (Amendment) (No. 2) Regulations 2023 provides for Schengen residents travelling into Ireland with prescribed Schedule 2 or Schedule 3 (under the Irish Misuse of Drugs Regulations 2017) narcotics or psychotropic substances for their own personal use while in possession of a certificate pursuant to Article 75 of the Schengen Acquis. Currently Ireland does not permit the importation from the Schengen area of a prescribed cannabis-based product as that is a Schedule 1 controlled drug. The work for the provision of Article 75 certificates for Irish residents travelling to the Schengen zone with prescribed narcotics/psychotropic substances for personal use is underway. However the decision on what prescribed products may be allowed enter a country is a decision for the destination Schengen country and not one for the Schengen resident's country of origin within the zone.